FDA Discusses Use of COVID-19 Vaccine In Kids Younger Than 12
The FDA is now focusing on the use of COVID-19 vaccines in children younger than 12.
On Thursday, an FDA advisory committee made up of doctors, researchers and scientists met virtually to discuss emergency authorization of COVID-19 vaccines for this age group.
The panel members say they’re trying to determine if the benefits outweigh any potential risks.
That includes making sure the risk of the vaccine in young children is less than the risk of hospitalization.
Moderna announced they have formally asked the FDA to give emergency use authorization for its vaccine in 12 to 17 year olds.